Preformulation of Small Molecule Drugs
Preformulation studies play a significant role in developing approaches to analytical and formulation development based on the physicochemical properties of small-molecule pharmaceuticals. This webinar will provide insights into the preformulation phase of drug development and will illustrate common issues encountered. Live: Thursday, Jun. 18, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after final airing Jun. 18, 2021 Register free
Register free: http://www.pharmtech.com/pt_w/molecule_drugs
Event Overview:
Preformulation studies play a significant role in developing approaches to analytical and formulation development based on the physicochemical properties of small-molecule pharmaceuticals. Data collected during pre-formulation informs:
- Dosage form selection and design
- Excipient choice
- Understanding of the feasibility of drug product development
- Regulatory strategies
This webcast will provide insights into the preformulation phase of drug development and will illustrate common issues encountered.
Key Learning Objectives:
- To identify the typical experiments performed in preformulation of small molecules
- To recognize how physicochemical properties will affect the choice of dosage form
- To spot potential formulation issues that could have been prevented by pre-formulation activities
Speaker: Frank Koppenhagen, Ph.D., Vice President, Pharmaceutical Development, Pace Analytical Life Sciences
Time and Date: Thursday, Jun. 18, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after final airing Jun. 18, 2021
Sponsor: Pace Analytical Sciences
Register free: http://www.pharmtech.com/pt_w/molecule_drugs
